Becton Dickinson (BDX)

Becton, Dickinson and Co. provides a wide range of medical devices and diagnostic products used in hospitals, doctors' offices, research labs, and other settings.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS (NYSE:STE) and its peers.

Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Zimmer Biomet (NYSE:ZBH) and the best and worst performers in the surgical equipment & consumables - diversified industry.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared in Q4, starting with Solventum (NYSE:SOLV).

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSE:BDX) and its peers.

Retirement investing should be kept simple in order to minimize mistakes. At its core, retirement investing is all about creating passive income.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst performers in the surgical equipment & consumables - diversified industry.

Over the past six months, BD’s shares (currently trading at $224.85) have posted a disappointing 5.9% loss, well below the S&P 500’s 5.1% gain. This might have investors contemplating their next move.

Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting results tomorrow afternoon. Here’s what to look for.

These 3 dividend stocks have increased their dividends for over 50 years and are trading at a discounted valuation.

The XBI was down 1.54% for the week, like off a cliff on Friday from a Wednesday high of $94.82.

Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.

Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be announcing earnings results tomorrow before market open. Here’s what to look for.

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30%.

The XLV bounced off the bottom this month up 4% to the $144 level led by biopharma and medtech.

S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's leadership, and AI investments.

Stocks to sell ahead of tariffs on Mexico: General Motors and Whirlpool have significant exposure to Mexican production facilities.

The healthcare sector is lagging over the past year and recent quarter with the XLV flat for 2024 and down over 4% for the recent quarter.